CLL, REFRACTORY
Clinical trials for CLL, REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new CLL, REFRACTORY trials appear
Sign up with your email to follow new studies for CLL, REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial tests cholesterol pill to boost leukemia fight
Disease control CompletedThis early-stage study tested the safety of adding a common cholesterol-lowering drug (pitavastatin) to a standard leukemia treatment (venetoclax). It involved 6 adults with either chronic lymphocytic leukemia (CLL) or acute myeloid leukemia (AML). The main goal was to find the s…
Matched conditions: CLL, REFRACTORY
Phase: PHASE1 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Researchers map the uncertain path after leukemia drugs fail
Knowledge-focused CompletedThis study looked back at the medical records of 152 adults with chronic lymphocytic leukemia (CLL) to understand what happens after two common types of oral medications stop working. The goal was to see what treatments doctors tried next and how patients responded, because there…
Matched conditions: CLL, REFRACTORY
Sponsor: French Innovative Leukemia Organisation • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC